A Rheovara productBIMA is designed for collaboration across neonatology, developmental pediatrics, rehabilitation, movement science, engineering, data science, and research operations.
Careful observation. Responsible research. Better questions about early movement.
Clinical partners can help define meaningful populations, recording conditions, outcomes, exclusion criteria, artifact labels, and follow-up schedules. Their input is also essential for usability, safety, and interpretation.
Strong studies need preregistered hypotheses, participant-level splits, standardized sensor placement, consistent age definitions, quality-control procedures, and sufficiently diverse cohorts. Shared data dictionaries and versioned exports make later analysis more dependable.
Hardware and software work should document sampling rate, clock drift, dropped samples, calibration, coordinate systems, firmware version, camera properties, and post-processing provenance. Improvements must be tested without changing the meaning of previously collected data.
Video and movement data can be sensitive. A healthcare-ready study requires governance for access, encryption, retention, deletion, audit trails, de-identification, incident response, and approved data-sharing agreements. A folder of downloaded files is not enough.
The best partnership begins with a specific population, age window, clinical or developmental outcome, and study design. From there, the team can determine whether BIMA’s synchronized capture approach is appropriate and what validation is required.